Second, whether the Shh pathway is involved in thyroid tumor initiation or facilitates tumor development initiated by oncogenes, such as mutant BRAF, RAS, or RET, needs to be verified in a transgenic mouse model. This evidence concerns the gene RET and thyroid tumor.